|
HY-140830-25mg
|
MedChemexpress LLC
|
m-PEG12-azide [CAS 2170098-29-8]
|
|
Cancer-programmed cell death
|
|
|
HY-140317-100mg
|
MedChemexpress LLC
|
m-PEG12-DBCO
|
|
Cancer-programmed cell death
|
|
|
HY-140317-50mg
|
MedChemexpress LLC
|
m-PEG12-DBCO
|
|
Cancer-programmed cell death
|
|
|
HY-140832-100mg
|
MedChemexpress LLC
|
m-PEG24-azide [CAS 2563873-82-3]
|
|
Cancer-programmed cell death
|
|
|
HY-140832-50mg
|
MedChemexpress LLC
|
m-PEG24-azide [CAS 2563873-82-3]
|
|
Cancer-programmed cell death
|
|
|
HY-130578-100mg
|
MedChemexpress LLC
|
m-PEG2-azide [CAS 215181-61-6]
|
|
Cancer-programmed cell death
|
|
|
HY-130578-250mg
|
MedChemexpress LLC
|
m-PEG2-azide [CAS 215181-61-6]
|
|
Cancer-programmed cell death
|
|
|
HY-130578-50mg
|
MedChemexpress LLC
|
m-PEG2-azide [CAS 215181-61-6]
|
|
Cancer-programmed cell death
|
|
|
HY-140827-100mg
|
MedChemexpress LLC
|
m-PEG3-azide [CAS 74654-06-1]
|
|
Cancer-programmed cell death
|
|
|
HY-140828-100mg
|
MedChemexpress LLC
|
m-PEG4-azide [CAS 606130-90-9]
|
|
Cancer-programmed cell death
|
|
|
HY-140828-50mg
|
MedChemexpress LLC
|
m-PEG4-azide [CAS 606130-90-9]
|
|
Cancer-programmed cell death
|
|
|
HY-140315-100mg
|
MedChemexpress LLC
|
m-PEG4-NH-DBCO [CAS 2228857-36-9]
|
|
Cancer-programmed cell death
|
|
|
HY-140315-25mg
|
MedChemexpress LLC
|
m-PEG4-NH-DBCO [CAS 2228857-36-9]
|
|
Cancer-programmed cell death
|
|
|
HY-140315-50mg
|
MedChemexpress LLC
|
m-PEG4-NH-DBCO [CAS 2228857-36-9]
|
|
Cancer-programmed cell death
|
|
|
HY-115374-100mg
|
MedChemexpress LLC
|
m-PEG6-azide [CAS 1043884-49-6]
|
|
COVID-19-immunoregulation
|
|
|
HY-115374-250mg
|
MedChemexpress LLC
|
m-PEG6-azide [CAS 1043884-49-6]
|
|
COVID-19-immunoregulation
|
|
|
HY-115374-50mg
|
MedChemexpress LLC
|
m-PEG6-azide [CAS 1043884-49-6]
|
|
COVID-19-immunoregulation
|
|
|
HY-135932-100mg
|
MedChemexpress LLC
|
m-PEG8-O-alkyne [CAS 880081-81-2]
|
|
Cancer-programmed cell death
|
|
|
HY-135932-25mg
|
MedChemexpress LLC
|
m-PEG8-O-alkyne [CAS 880081-81-2]
|
|
Cancer-programmed cell death
|
|
